VAERS Explorer
Back to explore

Report #2881340

Received Jan 10, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
NY
Recovered
Unknown
Vaccinated
Jan 6, 2026
Onset
Jan 6, 2025
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.1Y015179—

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

no adverse event; a temperature excursion for GARDASIL-9. The nurse states that the excursion occurred on 29 DEC-2025 and the dose was administered on 6-JAN-2026; This spontaneous report was received from a Nurse Practitioner and refers to a 11-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. A temperature excursion for Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) occurred on 29 DEC-2025 and on 06-Jan-2026, the patient was vaccinated with an improperly stored dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) lot #Y015179, expiration date: 28-Jan-2027, dose number 1 (strength, dose, route and anatomical location were not provided). The Temperature excursion was: 27.7°C, time frame: 10 Hours 15 Minutes and there was no previous temperature excursion. No adverse events reported.